ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
This clinical investigation aims at demonstrating that NCX-4240 is effective and safe in decreasing the number of days where adenoviral conjunctivis is detected in the eye and in reducing the duration and/or the severity of the signs and symptoms of adenoviral conjunctivis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Reducing Adenoviral Patient Infected Days#852585
- A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery#833485
- The Accuracy of Home Monitoring for Acute Macular Degeneration (AMD) Disease Activity#1047861
- A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration#803155
- An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis#849398
Record · ID 903434
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive